Rigel Pharmaceuticals (RIGL) EPS (Basic) (2010 - 2026)
Rigel Pharmaceuticals (RIGL) recorded quarterly EPS (Basic) of $0.47 in Q1 2026, down 96.84% quarter-over-quarter from $14.88 in Q4 2025, and down 26.56% on a YoY basis from $0.64 in Q1 2025.
Rigel Pharmaceuticals (RIGL) EPS (Basic) (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.47 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 26.56% year-over-year to $0.47; the TTM figure through Mar 2026 stood at $20.23 (up 863.33% YoY), while the FY2025 annual figure was $20.4, up 1960.61% from the prior year.
- EPS (Basic) was $0.47 for Q1 2026 at Rigel Pharmaceuticals, down from $14.88 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $14.88 in Q4 2025 to a low of -$3.09 in Q4 2022.
- Historically, EPS (Basic) has averaged $1.04 across 5 years, with a median of -$0.06 in 2024.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) plunged 2107.14% in 2022, then surged 5650.0% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$3.09 in 2022, then soared by 101.62% to $0.05 in 2023, then surged by 1520.0% to $0.81 in 2024, then jumped by 1737.04% to $14.88 in 2025, then slumped by 96.84% to $0.47 in 2026.
- The last three EPS (Basic) figures came in at $0.47 (Q1 2026), $14.88 (Q4 2025), and $1.55 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | 0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 14.88 |
| Sep 30, 2025 | 1.55 |
| Jun 30, 2025 | 3.33 |
| Mar 31, 2025 | 0.64 |
| Dec 31, 2024 | 0.81 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.47 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | -3.09 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.08 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.14 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.08 |